Fitxers

936506.pdf (935.22 KB)

Tipus de document

Article

Versió

Versió publicada

Data de publicació

2026-01-23

Llicència de publicació

cc-by (c) Boscà, A. et al., 2026
Si us plau utilitzeu sempre aquest identificador per citar o enllaçar aquest document: https://hdl.handle.net/2445/229245

Should We Continue Liver Transplantation in Spain for Hepatic Metastases from Neuroendocrine Tumors?

Títol de la revista

Autors

Director/Tutor

ISSN de la revista

Títol del volum

Recurs relacionat

https://doi.org/10.3390/jcm15030938

Resum

Background/Objectives: Despite the long-standing history of liver transplantation (LT) in Spain, no multicenter study has reviewed national outcomes for LT in metastatic neuroendocrine tumors (NETs). In the current era of transplant oncology, auditing these results is essential to refine patient selection and improve long-term outcomes. Methods: This retrospective observational study analyzed data from 13 centers, including 91 patients who underwent LT for NET between 1995 and 2024. Patients were stratified into two groups: Milan IN (those meeting the Milan criteria) and Milan OUT (the remainder). Results: Recurrence occurred in 57.1% of cases, and overall mortality was 51.6%. Of the 91 patients, 71 (78.0%) were Milan IN and 20 (22.0%) were Milan OUT. Five-year overall survival was 71.0% in Milan IN and 58.0% in Milan OUT, with a statistically significant difference. The 5-year disease-free survival (DFS) rate was 58.8% in Milan IN and 36.3% in Milan OUT; this difference was not statistically significant. Conclusions: In conclusion, strict adherence to Milan criteria and incorporation of modern prognostic factors are critical to optimize long-term survival in LT for NET. While the overall outcomes in this historical cohort are modest, future improvements are expected through more rigorous selection and the potential use of bridging or downstaging therapies.

Matèries

Trasplantament hepàtic, Metàstasi

Matèries (anglès)

Hepatic transplantation, Metastasis

Citació

Col·leccions

Articles publicats en revistes (Ciències Clíniques)
Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL))

Citació

BOSCÀ ROBLEDO, Andrea, et al. Should We Continue Liver Transplantation in Spain for Hepatic Metastases from Neuroendocrine Tumors?. Journal of Clinical Medicine. 2026. Vol. 15, num. 3. ISSN 2077-0383. [consulted: 25 of May of 2026]. Available at: https://hdl.handle.net/2445/229245

Exportar metadades

JSON - METS

Compartir registre